Konstantinos Tzortzakis is Co-Founder and Chief Business Officer at Anodyne Nanotech, a Boston-based biotechnology company revolutionizing drug delivery through patented transdermal microneedle systems.

An engineer turned entrepreneur, Konstantinos earned a Master of Engineering in Electrical and Computer Engineering from the National Technical University of Athens and an M.Sc. in Innovation and Management from Tufts University, where he co-founded Anodyne Nanotech.

Konstantinos bridges deep engineering expertise with business strategy, making cross-disciplinary team alignment a core strength, and he also mentors early-stage biotech startups at Nucleate.

At Anodyne Nanotech, he leads strategic planning, business development, and market analysis for the Hero Patch platform, which delivers milligrams of biologics transdermally without injections.

Anodyne Nanotech has raised $9.5M in funding from investors including Big Pi Ventures, Velocity Partners, and Relativity Healthcare Fund, and is targeting GLP-1 weight-loss drugs like Wegovy and Ozempic as a key commercial application.